Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 38 of 45
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cancer Genetics, NovellusDx agree to merge

Cancer Genetics will be the surviving entity and expects to remain listed on the Nasdaq Stock Market. This transaction will combine Cancer Genetics’ scale, expansive test portfolio and

Novo Nordisk to slash 400 jobs in R&D restructuring

The company is restructuring its R&D organization to accelerate the expansion and diversification of its pipeline across severe chronic diseases, in addition to supporting increased investment in transformational